Company record
AbbVie Inc.
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about AbbVie Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jun 3 | Class III | AbbVie Inc. Drug |
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10. Failed Stability Specifications |